Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk
Piera Rizzolo(Sapienza University of Rome), Laura Ottini(Mount Sinai Hospital), Ines Zanna(Piedmont Reference Center for Epidemiology and Cancer Prevention), Simonetta Bianchi(University of Florence), Jacopo Azzollini(Fondazione IRCCS Istituto Nazionale dei Tumori), Siranoush Manoukian(Fondazione IRCCS Istituto Nazionale dei Tumori), Gianluca Tedaldi(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Marco Montagna(Azienda Ospedale - Università Padova), Anna Coppa(Sapienza University of Rome), Liliana Varesco(Istituti di Ricovero e Cura a Carattere Scientifico), Agostino Bucalo(Sapienza University of Rome), Laura Cortesi(Azienda Ospedaliero-Universitaria di Modena), Domenico Palli(Piedmont Reference Center for Epidemiology and Cancer Prevention), Valentina Silvestri(Cancer Research UK Cambridge Center), Virginia Valentini(Sapienza University of Rome), Bernardo Bonanni(European Institute of Oncology), Antonio Russo(University of Palermo), Paolo Peterlongo(IFOM), Paolo Radice(IFOM), Maria Grazia Tibiletti(University of Insubria), Giuseppe Giannini(Istituto Pasteur), Alessandra Viel(Centro di Riferimento Oncologico), Veronica Zelli(University of L'Aquila)
Cited by 15
Related Papers
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k
Meat, Fish, and Colorectal Cancer Risk: The European Prospective Investigation into Cancer and Nutrition
|JNCI Journal of the National Cancer Institute|2005|865
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
|Genetics in Medicine|2019|666
Body size and breast cancer risk: Findings from the European prospective investigation into cancer and nutrition (EPIC)
|International Journal of Cancer|2004|580